相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thioredoxin 1 and thioredoxin 2 have opposed regulatory functions on hypoxia-inducible factor-1α
Jie Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration
Martin K. C. Ng et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Novel thioredoxin inhibitors paradoxically increase hypoxia-inducible factor-α expression but decrease functional transcriptional activity, DNA binding, and degradation
Dylan T. Jones et al.
CLINICAL CANCER RESEARCH (2006)
Antitumor quinols: Role of glutathione in modulating quinol-induced apoptosis and identification of putative cellular protein targets
Eng-Hui Chew et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Characterization of the expression of the hypoxia-induced genes neuritin, TXNIP and IGFBP3 in cancer
Sébastien Le Jan et al.
FEBS LETTERS (2006)
Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung
JH Park et al.
RESPIROLOGY (2006)
Hcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinoma
PM Nissom et al.
FEBS LETTERS (2006)
Antioxidant enzymes in oligodendroglial brain tumors: association with proliferation, apoptotic activity and survival
J Sally et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors thioredoxin reductase
G Powis et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Polyamine depletion partially reduces the radiation-induced cell death via cell cycle delay mediated by thioredoxin
MS Moon et al.
CELL BIOLOGY AND TOXICOLOGY (2006)
The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma
AF Baker et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2006)
Anti-proliferative and anti-tumor effects of antisense oligonucleotide GTI-2601 targeted against human thioredoxin
Y Lee et al.
ANTI-CANCER DRUGS (2006)
Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1 alpha in non-small cell lung cancer
I Csiki et al.
CANCER RESEARCH (2006)
High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer
SJ Kim et al.
CLINICAL CANCER RESEARCH (2005)
A redox signature score identifies diffuse large B-cell lymphorna patients with a poor prognosis
ME Tome et al.
BLOOD (2005)
Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients
P Surowiak et al.
VIRCHOWS ARCHIV (2005)
Elucidation of thioredoxin as a molecular target for antitumor quinols
TD Bradshaw et al.
CANCER RESEARCH (2005)
Prediction of docetaxel response in human breast cancer by gene expression profiling
K Iwao-Koizumi et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors
JS Ungerstedt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mitochondrial thioredoxin reductase inhibition by gold(I) compounds and concurrent stimulation of permeability transition and release of cytochrome c
MP Rigobello et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Up-regulation of the redox mediators thioredoxin and apurinic/apyrimidinic excision (APE)/ref-1 in hypoxic microregions of invasive cervical carcinomas, mapped using multispectral, wide-field fluorescence image analysis
D Hedley et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity
EJ Meuillet et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide
CH Lillig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cysteine oxidation of tau and microtubule-associated protein-2 by peroxynitrite - Modulation of microtubule assembly kinetics by the thioredoxin reductase system
LM Landino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth
M McNaughton et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Oxidative stress and thioredoxin-interacting protein promote intravasation of melanoma cells
GC Cheng et al.
EXPERIMENTAL CELL RESEARCH (2004)
The thioredoxin system - From science to clinic
S Gromer et al.
MEDICINAL RESEARCH REVIEWS (2004)
Thioredoxin inhibits microvascular endothelial capillary tubule formation
AR Farina et al.
EXPERIMENTAL CELL RESEARCH (2003)
Thioredoxin restores nitric oxide-induced inhibition of protein kinase C activity in lung endothelial cells
K Kahlos et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues
HJ Kim et al.
CELL BIOLOGY AND TOXICOLOGY (2003)
A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines
CJ Shi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Thioredoxin reductase 1 expression in colon cancer:: Discrepancy between in vitro and in vivo findings
S Lechner et al.
LABORATORY INVESTIGATION (2003)
Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif
WH Watson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival
J Raffel et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2003)
Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases
MP Mehta et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The thioredoxin-like fold: hidden domains in protein disulfide isomerases and other chaperone proteins
PM Clissold et al.
BIOESSAYS (2003)
Characterization of human thioredoxin-like 2 -: A novel microtubule-binding thioredoxin expressed predominantly in the cilia of lung airway epithelium and spermatid manchette and axoneme
CM Sadek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Elevated serum levels of thioredoxin in patients with acute exacerbation of asthma
Y Yamada et al.
IMMUNOLOGY LETTERS (2003)
Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses
R Lichtenfels et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2003)
4-substituted 4-hydroxycyclohexa-2,5-dien-1-ones with selective activities against colon and renal cancer cell lines
G Wells et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Expression of antioxidant enzymes in bronchial metaplastic and dysplastic epithelium
Y Soini et al.
LUNG CANCER (2003)
Enhancement of metabolic oxidative stress-induced cytotoxicity by the thioredoxin inhibitor 1-methylpropyl 2-imidazolyl disulfide is mediated through the ASK1-SEK1-JNK1 pathway
YJ Lee et al.
MOLECULAR PHARMACOLOGY (2002)
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin
LM Butler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Effects of a new anti-rheumatic drug KE-298 and its active metabolite: KE-758 on secretion of thioredoxin and on the level of intracellular glutathione in human monocytes and T cells
M Sugimoto et al.
MOLECULAR IMMUNOLOGY (2002)
Reactive oxygen species, antioxidants, and the mammalian thioredoxin system
J Nordberg et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
New inhibitors of the thioredoxin-thioredoxin reductase system based on a naphthoquinone spiroketal natural product lead
P Wipf et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Human thioredoxin reductase is efficiently inhibited by (2,2′:6′,2-terpyridine)platinum(II) complexes.: Possible implications for a novel antitumor strategy
K Becker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
分享论文
